Metoclopramide Core Patient Variables Metoclopramide Core Patient Variables

Metoclopramide core patient variables metoclopramide

This preview shows page 36 - 43 out of 69 pages.

Metoclopramide: Core Patient Variables Metoclopramide: Core Patient Variables Health status Assess symptoms. Life span and gender Pregnancy Category B drug Environment Oral given in any environment; IV given in acute care settings
Image of page 36
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Metoclopramide: Nursing Diagnoses and Outcomes Metoclopramide: Nursing Diagnoses and Outcomes Risk for Self-Directed Violence secondary to adverse effects of drug therapy Desired outcome: The patient will do no self-harm related to depression from drug therapy. Powerlessness related to extrapyramidal effects, Parkinson-like symptoms, or tardive dyskinesia secondary to adverse effects of drug therapy Desired outcome: The patient will make decisions regarding own care, treatment, and future (when possible) while on drug therapy. Risk for Injury related to drowsiness, fatigue, insomnia, confusion, and hallucination secondary to adverse effects of drug therapy Desired outcome: The patient will not suffer injury while on drug therapy.
Image of page 37
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Metoclopramide: Planning and Interventions Metoclopramide: Planning and Interventions Maximizing therapeutic effects Give oral doses 30 minutes before each meal. Do not administer metoclopramide concurrently with anticholinergic drugs. Minimizing adverse effects Monitor for evidence of depression. Withhold the dose and notify the prescriber if Parkinson-like symptoms occur.
Image of page 38
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Metoclopramide: Teaching, Assessment, and Evaluation Metoclopramide: Teaching, Assessment, and Evaluation Patient and family education Tell patients to take metoclopramide 30 minutes before meals. Discuss side effects of drug. Caution patients to avoid alcoholic beverages, sedatives, and other CNS depressants. Ongoing assessment and evaluation With careful monitoring and follow-up assessments, therapy can be considered successful if the patient’s GI complaints diminish.
Image of page 39
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question Question To promote optimal effectiveness of the drug, metoclopramide should be given A. 30 minutes before meals B. At the start of the meal C. 30 minutes after the meal D. Three times a day without regard to meal times
Image of page 40
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer Answer A. 30 minutes before meals Rationale: Metoclopramide should be given 30 minutes before meals to achieve maximum effectiveness.
Image of page 41
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Digestive Enzymes Digestive Enzymes Digestive enzymes are responsible for breaking down food into forms that can be absorbed easily in the GI tract.
Image of page 42
Image of page 43

You've reached the end of your free preview.

Want to read all 69 pages?

  • Fall '16
  • Wolters Kluwer Health, Lippincott Williams & Wilkins

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture